Novo Nordisk, a world leader in diabetes care, today kicked off the first NovoLog® Community Star contest. As part of the program, type 2 diabetes patients successfully managing their blood sugar with NovoLog® (insulin aspart [rDNA origin] injection) are invited to visit www.novolog.com and tell us how they’re giving back to their local communities.
Now through March 15, NovoLog® patients can submit their story and photo online for the chance to be crowned a NovoLog® Community Star. Finalists will be selected by a panel of judges, and each will receive a $5,000 donation to a local diabetes-related organization of their choice. One grand prize winner will also receive a one-year online subscription to Weight Watchers® to help with their diabetes management.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59947-novo-nordisk-first-novolog-community-star-contest-type-2-diabetes-patients
A new Economist Intelligence Unit (EIU) report titled The Silent Pandemic: Tackling Hepatitis C with Policy Innovation, made possible as a result of an educational grant from Janssen Pharmaceutica NV and published today, highlights the urgent need for countries around the world to develop strategies to tackle head-on the growing social and economic issues associated with Hepatitis C (HCV).
While the total number of infected individuals is unknown due to a lack of available data, the World Health Organization (WHO) estimates that approximately 150 million people globally are currently living with the blood-borne infectious disease, HCV. Of these, up to two thirds will develop chronic liver disease and one in five will develop cirrhosis. HCV is also the leading cause of liver transplantation worldwide and in the US the disease now accounts for more deaths than HIV.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58671-janssen-silent-pandemic-hepatitis-c
We have over 200 years of combined experience in investigating, studying, arresting, and prosecuting identity theft rings. We have dedicated our lives to law enforcement. Now we bring that experience to you.
After 40 years at the helm of one of the largest global hotel empires, executive chairman of Marriott International (NYSE: MAR), J.W. “Bill” Marriott, Jr., offers a revealing and candid glimpse of what he has learned in a lifetime of hosting the world, in his new book Without Reservations: How A Family Root Beer Stand Grew Into a Global Hotel Company. The book is now available for $9.99 through all major eRetailers, including Amazon, iTunes and Barnes & Noble. Hard covers will be available in spring 2013.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54180-marriott-international-ceo-bill-marriott-new-book-without-reservations
Upsher-Smith Laboratories, Inc. [http://www.upsher-smith.com] today announced that its epilepsy-focused educational website, Epilog.us [http://www.Epilog.us], now features a panel discussion of leading experts on the role of rational polytherapy in the treatment of patients with epilepsy, led by Dr. Barry Gidal, Professor of Pharmacy and Neurology/Division Chair, University of Wisconsin. Dr. Gidal also brings forward discussion on the mechanism of action of specific antiepileptic drugs (AEDs). Additional topics include: AED pharmacokinetics; patient adherence and AEDs; and drug interactions.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59891-upsher-smith-epilog-us-pharmacodynamics-of-antiepileptic-drugs-aeds